ARVN · ARVINAS, INC.

NasdaqHealthcareBiotechnology

Arvinas Inc Is A Clinical-Stage Biotechnology Company Focused On Improving The Lives Of Patients Suffering From Debilitating And Life-Threatening Diseases Through The Discovery, Development, And Commercialization Of Therapies That Degrade Disease-Causing Proteins. The Company Is Using Its Proteolysis Targeting Chimera, A Protein Degradation Platform, To Develop Therapeutics Designed To Harness The Body'S Own Natural Protein Disposal System To Selectively And Efficiently Degrade And Remove Disease-Causing Proteins. Its Clinical Development Program Includes Various Product Candidates Such As Arv-102, Arv-806, Arv-393, Arv-027, And Vepdegestrant, In Their Different Stages Of Development, Being Developed To Target Certain Harmful Proteins Causing Oncology And Neurology-Related Diseases.

HealthcareNasdaqUS

FLOAT

54.6M

FREE FLOAT %

85%

SHARES O/S

64.5M

MARKET CAP

$477.3M

EXCHANGE

Nasdaq

COUNTRY

ARVN Catalyst History

No catalysts recorded for ARVN yet

Day Trader Sniper hasn't classified a publishable catalyst for ARVN yet. New events appear here as they're scored.

Be early on the next ARVN spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

ARVN · ARVINAS, INC.

ARVN Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.